[HTML][HTML] Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis
…, E Thirunavukkarasu, GK Haines, AJ Impens… - Arthritis research & …, 2011 - Springer
Introduction Systemic sclerosis (SSc) is characterized by fibrosis and microvascular
abnormalities including dysregulated angiogenesis. Chemokines, in addition to their …
abnormalities including dysregulated angiogenesis. Chemokines, in addition to their …
Randomized placebo-controlled crossover trial of tadalafil in Raynaud's phenomenon secondary to systemic sclerosis
E Schiopu, VM Hsu, AJ Impens, JA Rothman… - The Journal of …, 2009 - jrheum.org
Objective. Raynaud’s phenomenon (RP) is an important clinical feature of systemic sclerosis
(SSc) for which consistently effective therapies are lacking. The study was designed to …
(SSc) for which consistently effective therapies are lacking. The study was designed to …
[HTML][HTML] Digital ischemia in scleroderma spectrum of diseases
E Schiopu, AJ Impens, K Phillips - International journal of …, 2010 - hindawi.com
Systemic Sclerosis (Scleroderma, SSc) is a disease of unknown etiology characterized by
widespread vasculopathy and extracellular matrix deposition leading to fibrosis and …
widespread vasculopathy and extracellular matrix deposition leading to fibrosis and …
[HTML][HTML] PDE-5 inhibitors in scleroderma raynaud phenomenon and digital ulcers: current status of clinical trials
AJ Impens, K Phillips, E Schiopu - International Journal of …, 2011 - hindawi.com
Systemic sclerosis- (SSc-) related vasculopathy, as manifested by Raynaud's Phenomenon (RP)
and digital ulcers (DUs), is associated with significant impairment of the quality of life …
and digital ulcers (DUs), is associated with significant impairment of the quality of life …
Influences of clinical features of systemic sclerosis (SSc) on the Michigan Hand Questionnaire (MHQ)
Conclusions Digital ulcers and skin thickening had minimal impact whereas tendon
involvement dominated patient ratings of hand function. No significant correlations were found …
involvement dominated patient ratings of hand function. No significant correlations were found …
Doppler echocardiography overestimates pulmonary hypertension in patients with scleroderma interstitial lung disease
KM Chan, E Tishkowski, AJ Impens, T Ojo… - Chest, 2008 - journal.chestnet.org
PURPOSE: The diagnosis of pulmonary hypertension (PH) in patients with scleroderma
related interstitial lung disease (SILD) is important for patient management. Doppler …
related interstitial lung disease (SILD) is important for patient management. Doppler …
[PDF][PDF] Sexual activity and functioning in female scleroderma patients
AJ Impens, J Rothman, E Schiopu… - Clinical & …, 2009 - researchgate.net
Objective. Few studies exist on sexual activity and functioning in female patients with systemic
sclerosis (SSc, scleroderma). We studied the patientreported impact of SSc on sexual …
sclerosis (SSc, scleroderma). We studied the patientreported impact of SSc on sexual …
[PDF][PDF] Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis
AJ Impens, K Phillips, B Kahaleh… - Age …, 2011 - arthritis-research.biomedcentral.com
Introduction: Systemic sclerosis (SSc) is characterized by fibrosis and microvascular
abnormalities including dysregulated angiogenesis. Chemokines, in addition to their …
abnormalities including dysregulated angiogenesis. Chemokines, in addition to their …
Sexual Activity and Functioning in Female Scleroderma (SSc) Patients.
AJ Impens, J Guerriere, E Schiopu, N Gendrano… - Rheumatology - researchgate.net
Systemic sclerosis (scleroderma or SSc) is a chronic multisystem disorder involving the skin,
joints, gut, lungs, kidney, heart, and blood vessels. It has a profound impact on quality of life …
joints, gut, lungs, kidney, heart, and blood vessels. It has a profound impact on quality of life …
[CITATION][C] Controlled trial of tadalafil in Raynaud phenomenon (RP) secondary to systemic sclerosis (SSc)
E Schiopu, VM Hsu, AJ Impens, JA Guerriere-Rothman… - Arthritis Rheum, 2006